Concord Health Partners invests in Cedar's Series C Funding

Concord Health Partners, a healthcare focused investment firm, announced today its investment in the Series C funding of Cedar, a leading patient engagement and financial technology platform. Cedar facilitates patient-centric financial engagement across the entire care journey through personalized outreach and a seamless user experience.  Over the past year, Cedar has realized substantial growth through innovative institutional collaborations, including a partnership with Novant Health that was announced on June 22. Concord's participation in Cedar's Series C funding will enable the company to accelerate investment in core product development, which is even more crucial in the aftermath of the COVID-19 pandemic.